SNOA stock

Sonoma Pharmaceuticals Inc (SNOA) earnings · rev $19.5M

These earnings events as JSON? API free 100/day

Sonoma Pharmaceuticals Inc (SNOA) is a drug manufacturers - specialty & generic company listed on US.

This SNOA earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.

Latest reported SNOA revenue for 2026-03-31 was $19.5M. Net income was -$3.2M. Revenue was up 36.7% from 2025-03-31 to 2026-03-31. SNOA currently screens at market cap $4.9M.

When the next SNOA 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.

The change that matters: Revenue was up 36.7% from 2025-03-31 to 2026-03-31. An earnings headline that ignores that move is noise.

Not investment advice. Full SNOA research stays on the stock page; the tape stays on the quote page.

SNOA earnings FAQ

What are SNOA's latest revenue and net income?

Latest cached Sonoma Pharmaceuticals Inc (SNOA) revenue for Mar 31, 2026 was $19.5M. Net income was -$3.2M. Statements: https://lician.com/financials/snoa

What is SNOA's latest diluted EPS?

Latest cached Sonoma Pharmaceuticals Inc (SNOA) diluted EPS for Mar 31, 2026 was -$1.89.

What period does the latest SNOA earnings print cover?

The latest cached Sonoma Pharmaceuticals Inc (SNOA) earnings print covers Mar 31, 2026. The prior cached period on this page is Mar 31, 2025.

How did SNOA revenue change from the prior cached period?

Cached Sonoma Pharmaceuticals Inc (SNOA) revenue was up 36.7% from $14.3M (Mar 31, 2025) to $19.5M (Mar 31, 2026). Statements: https://lician.com/financials/snoa

Where are SNOA earnings listed?

Cached earnings facts for Sonoma Pharmaceuticals Inc (SNOA) are listed at https://lician.com/earnings/snoa. Statements: https://lician.com/financials/snoa

Not investment advice.

Full SNOA analysis